共 24 条
- [1] Omalizumab Improves Quality of Life (QoL) in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU) As Assessed By the Dermatology Life Quality Index (DLQI): A Post-Hoc Analysis of Percent Change from Baseline to Week 12 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB127 - AB127
- [5] Adaptation and validation of the Bengali version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2023, 89 (03): : 385 - 392
- [9] Adaptation and Validation of the Israeli Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (08): : 461 - 465
- [10] Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q2oL) Health and Quality of Life Outcomes, 17